Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
69 employees · est. 2019 · Allschwil, Switzerland
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.
108 employees · est. 2012 · France
Inventiva Pharma is the older company (2019 vs 2012).
Side-by-Side Comparison
| Metric | Alentis Therapeutics | Inventiva Pharma |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2012 older |
| Headquarters | ||
| Headquarters | Allschwil, Switzerland | France |
| Employees | ||
| Employees | 69 | 108 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biopharma, Biotechnology, Medical Devices |
| Funding Stage | ||
| Funding Stage | Series D | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $364.50M | $276.30M |
| Funding Rounds | ||
| Funding Rounds | 4 | 10 |
| Services | ||
| Services | Development of anti-Claudin-1 ADCs, Clinical trials for monoclonal antibodies, Fibrosis study results publication, Leadership in therapeutic development | Development of oral small molecule therapies, Clinical trials and research programs, Drug candidate development for unmet medical needs |
| Target Customers | ||
| Target Customers | Cancer patients, Patients with organ fibrosis, Healthcare professionals, Biotech investors | Patients with fibrosis, Patients with lysosomal storage disorders, Patients with oncology needs, Health care providers and researchers focusing on NASH and MPS |
| Taxonomy | ||
| Taxonomy | Claudin-1, Tumor Treatment, Organ Fibrosis, Antibody-drug Conjugates, Oncology, Liver Fibrosis, Kidney Fibrosis, Lung Fibrosis, Cancer Therapy, Clinical-stage Biotechnology, Multi-organ Fibrosis, Drug Discovery, Drug Development, Rare Diseases, Nephrology | Biopharmaceutical, Clinical-stage, Oral Small Molecule Therapies, Fibrosis, Lysosomal Storage Disorders, Oncology, NASH (Nonalcoholic Steatohepatitis), MPS (Mucopolysaccharidoses), SSc (Systemic Sclerosis), Drug Discovery, Nuclear Receptors, Transcription Factors, Epigenetic Modulation, Proprietary Molecules, Research And Development |
| Website | ||
| Website | alentis.ch | inventivapharma.com |
About Alentis Therapeutics
Alentis Therapeutics, founded in 2019, is a pioneering clinical-stage biotechnology company with a focus on developing breakthrough treatments for Claudin1-positive tumors and organ fibrosis. The company is based in the pharma-biotech hub of Basel, Switzerland. The company specializes in first-in-c...
About Inventiva Pharma
Inventiva Pharma, founded in 2012 and headquartered in France, is a clinical-stage biopharmaceutical company specializing in developing oral small molecule therapies for critical unmet medical needs. Their research targets areas such as fibrosis, lysosomal storage disorders, and oncology, with speci...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Alentis Therapeutics and Inventiva Pharma — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Alentis Therapeutics and Inventiva Pharma — by email.
Frequently Asked Questions
Compare Alentis Therapeutics with someone else
Start typing a company name or domain.